Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Pharmaceutical companies breathed a sigh of relief on Wednesday, but the tariff reprieve could prove fleeting.
US FDA approves freeze-dried version of Bavarian Nordic's mpox, smallpox vaccine
Denmark's Bavarian Nordic said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its ...
European shares recover ground as markets brace for US tariff deadline
European shares rebounded on Tuesday from a two-month low touched in the previous session, while the market braced for an ...
GlobalData on MSN3d
FDA approves Bavarian Nordic’s freeze-dried mpox and smallpox vaccine
The formulation allows for greater stockpiling, with Bavarian Nordic already working with the US Government to add to vaccine ...
Bavarian Nordic’s Jynneos highlights unmet need for mpox prevention in HIV patients
This recent safety and effectiveness data regarding mpox vaccination with Jynneos is important and timely given the ongoing ...
European shares cautiously recover ahead of US tariff deadline
By Medha Singh and Sukriti Gupta (Reuters) -European shares rebounded on Tuesday after touching a two-month low in the ...
Explore more
Rheumatology Advisor2h
FDA Approves Freeze-Dried Formulation of Mpox, Smallpox Vaccine
The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).
The Pharma Letter6h
Research shows need for better mpox protection in HIV-positive patients
A new report from GlobalData has raised concerns over the effectiveness of mpox vaccines for people living with HIV. Findings ...
ETF Daily News2d
Bavarian Nordic A/S (OTCMKTS:BVNRY) Share Price Passes Below 200 Day Moving Average – Time to Sell?
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS ...
Morningstar4d
Bavarian Nordic Receives U.S. FDA Approval of Freeze-Dried Smallpox and Mpox Vaccine
COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the freeze-dried formulation of JYNNEOS ...
Yahoo Finance3d
Bavarian Nordic Receives U.S. FDA Approval of Freeze-Dried Smallpox and Mpox Vaccine
COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the freeze-dried formulation of JYNNEOS ® (Smallpox ...